It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility. After-hours trades for Insmed Incorporated (INSM) shows that investor sentiment remained intact, with the stock’s consolidated last price rising by $0.25, or 1.35%, to $18.75. The Insmed Incorporated has recorded 910,028 volume in the after hours trading session. Recently, Yahoo Finance discussed the stock, revealing that Insmed Provides Business Updates and Near-Term Strategic Outlook at 41st Annual J.P. Morgan Healthcare Conference.
Insmed Incorporated is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. At the end of the last regular session, the stock closed at $18.50 and fluctuated between $19.60 as its day high and $17.00 as its day low. The current market capitalization of Insmed Incorporated is $2.67B. A total of 5.22 million shares were traded on the day, compared to an average of 1.56M shares.
Insider trades are also considered as indicators of how a stock will perform in the future, in addition to stock predictions. During the recent three months, INSM has seen 3 BUY and 2 SELL insider trades, representing the acquisition of 75,000 and the disposition of 19,009 shares. Over the last 12 months, there were 29 BUYs and 31 SELLs from insiders. Insiders purchased 796,877 shares during that period but sold 465,396.
In the most recent transaction, Wise John Drayton sold 1,160 shares of INSM for 19.74 per share on Jan 05. After the transaction, the Chief Commercial Officer now owns 70,453 company shares. In a previous transaction on Jan 05, Smith Michael Alexander sold 720 shares at 19.72 per share. INSM shares that General Counsel, Senior VP owns now total 49,836.
Among the insiders who sold shares, Schaeffer Orlov S Nicole disposed of 1,448 shares on Jan 05 at a per-share price of $19.73. This resulted in the Chief People Strategy Officer holding 68,262 shares of INSM after the transaction. In another insider transaction, Lewis William sold 7,008 shares at $19.80 per share on Jan 05. Company shares held by the Chair and CEO now total 249,708.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. According to analysts who have offered 12-month price targets for INSM in the last 3 months, the mean price target is $41.62 with high estimates of $53.00 and low estimates of $28.00. In terms of 52-week highs and lows, INSM has a high of $28.94 and a low of $16.41.
As of this writing, INSM has an earnings estimate of -$0.97 per share for the current quarter. EPS was calculated based on a consensus of 8 estimates, with a high estimate of -$0.9 per share and a lower estimate of -$1.06. The company reported an EPS of -$0.8 in the last quarter, which was 10.10% higher than expectations of -$0.89.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information.
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 13 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for INSM is Hold with a score of 5.00. A total of 12 analysts rated the stock as Buy while 1 rated it as Overweight while 0 rated it as Hold. Among the other participants, 0 thought the stock was Underweight and 0 thought it should be Sold.